GRI Bio, Inc. - Common Stock (GRI)
2.0400
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 23rd, 4:04 AM EDT
Detailed Quote
Previous Close | 2.040 |
---|---|
Open | - |
Bid | 1.940 |
Ask | 2.080 |
Day's Range | N/A - N/A |
52 Week Range | 1.100 - 43.69 |
Volume | 0 |
Market Cap | 13.90M |
PE Ratio (TTM) | -0.0329 |
EPS (TTM) | -62.0 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 174,398 |
Chart
About GRI Bio, Inc. - Common Stock (GRI)
Gri Bio Inc is a biotechnology company focused on developing innovative therapies to enhance the immune response and improve the treatment of various diseases. The company leverages its proprietary technology platform to identify and create novel biopharmaceutical products aimed at addressing unmet medical needs in areas such as immunology and oncology. By harnessing the power of the immune system, Gri Bio strives to deliver breakthrough treatments that can significantly impact patient outcomes and contribute to advancements in modern medicine. Read More
News & Press Releases
Via Benzinga · July 22, 2025
- Video webcasts from participating companies now available here
Via ACCESS Newswire · July 22, 2025
GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.
Via Benzinga · April 1, 2025

GRI Bio just reported results for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

Via Benzinga · November 15, 2024

Via Benzinga · November 1, 2024

Via Benzinga · October 23, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 8, 2024

Via Benzinga · October 8, 2024

Via Benzinga · September 30, 2024

Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via InvestorPlace · July 22, 2024

Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!
Via InvestorPlace · July 18, 2024

Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares.
Via InvestorPlace · June 26, 2024

GRI Bio stock is down on Wednesday after the company announced a proposed public offering for some 2 million GRI shares.
Via InvestorPlace · June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via InvestorPlace · June 26, 2024